Quantum computing firm IonQ hires former JPMorgan Chase applied research head

Key Points

IonQ has hired the former head of applied research at JPMorgan Chase to help corporate clients of the quantum firm adopt next-generation hardware, algorithms and security, CNBC has learned.
Marco Pistoia, who was head of JPMorgan’s internal research group from 2020 to this year, will be joining IonQ as senior vice president of industry relations.
In his new role, Pistoia will report directly to IonQ CEO Niccolo de Masi and focus on helping corporations adopt both quantum computing and quantum-safe encryption.

Source

Finance

Warren Buffett’s Berkshire Hathaway reveals new position in Alphabet

November 14, 2025

Warren Buffett speaks during the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. CNBC Warren Buffett’s Berkshire Hathaway revealed a new position in Alphabet, making the Google parent the conglomerate’s 10th largest equity holding at the end of September, according to a regulatory filing. Berkshire disclosed a $4.3 billion stake in […]

Finance

Stocks making the biggest moves midday: Whirlpool, Topgolf Callaway, Nvidia, Stubhub & more

November 14, 2025

Check out the companies making the biggest moves midday: Scholar Rock — The Cambridge, Massachusetts-based biotech jumped 23% after saying it ” completed constructive and collaborative in-person Type A meeting ” with the FDA on Wednesday for a biologics license application for apitegromab, a spinal muscular atrophy treatment. Officials from Novo Nordisk’s Catalent Indiana joined […]

Finance

Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more

November 14, 2025

Check out the companies making headlines before the bell. Cidara Therapeutics — Shares of Cidara surged 103% after Merck agreed to buy the company for close to $9.2 billion in cash. Merck fell 1%. Avadel Pharmaceuticals — Danish drugmaker Lundbeck offered to acquire the pharmaceutical company for as much as $23 per share, topping biotech […]